The rapid growth of research on enzyme-mimetic catalysts (Enz-Cats) is expected to promote further advances in nanomedicine for biological detection, diagnosis and treatment of disease, especially tumors. ROS-based nanomedicines present fascinating potential in antitumor therapy owing to the rapid development of nanotechnology. In this review, we focus on the applications of Enz-Cats based on ROS in antitumor therapy. Firstly, the definition and category of ROS are introduced, and the key factors enhancing ROS levels are carefully elucidated. Then, the rationally engineered Enz-Cats different synthetic approaches with high ROS-producing efficiencies are comprehensively discussed. Subsequently, oncotherapy application of Enz-Cats is comprehensively discussed, which integrates diverse synergistic treatment modalities and exhibits high efficiency in ROS generation. Finally, the challenges and future research direction of this field are presented. This review is dedicated to unraveling the enigmas surrounding the interplay of nanomedicine and organisms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d4nr02026j | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Steering acidic oxygen reduction selectivity of single-atom catalysts through the second sphere effect.
Nat Commun
December 2024
Center of Artificial Photosynthesis for Solar Fuels and Department of Chemistry, School of Science, Westlake University, Hangzhou, China.
Natural enzymes feature distinctive second spheres near their active sites, leading to exquisite catalytic reactivity. However, incumbent synthetic strategies offer limited versatility in functionalizing the second spheres of heterogeneous catalysts. Here, we prepare an enzyme-mimetic single Co-N atom catalyst with an elaborately configured pendant amine group in the second sphere via 1,3-dipolar cycloaddition, which switches the oxygen reduction reaction selectivity from the 4e to the 2e pathway under acidic conditions.
View Article and Find Full Text PDFAnion Recognition-Directed Supramolecular Catalysis with Functional Macrocycles and Molecular Cages.
Acc Chem Res
November 2024
Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
Article Synopsis
- The text discusses the advancements in supramolecular chemistry, particularly focusing on how host molecules and noncovalent interactions can enhance catalytic processes through supramolecular catalysis.
- It highlights the significance of macrocyclic and cage-like compounds which mimic enzymes and possess unique recognition features, emphasizing the underutilization of directional binding sites in traditional host molecules.
- The study introduces a novel approach using tailor-made functionalized macrocycles and cages specifically designed for anion recognition, which enhances catalytic efficiency and stereocontrol in reactions by leveraging strong anion binding and cooperative interactions.
Photothermal amplified multizyme activity for synergistic photothermal-catalytic tumor therapy.
J Colloid Interface Sci
February 2025
Faculty of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun, Jilin 130024, PR China. Electronic address:
Nano-enzymatic catalytic therapy has been widely explored as a promising tumor therapeutic method with specific responsiveness to the tumor microenvironment (TME). However, the inherent lower and simplex catalytic efficiency impairs their anti-tumor efficacy. Therefore, developing novel nanozymes with relatively high and multiple catalytic characteristics, simultaneously enhancing the enzyme-like activity of nanozymes using the proper method, photothermal promoted catalytic property, is a reliable way.
View Article and Find Full Text PDFMulti-Enzyme Mimetic MoCu Dual-Atom Nanozyme Triggering Oxidative Stress Cascade Amplification for High-Efficiency Synergistic Cancer Therapy.
Angew Chem Int Ed Engl
January 2025
State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
Single-atom nanozymes (SAzymes) with ultrahigh atom utilization efficiency have been extensively applied in reactive oxygen species (ROS)-mediated cancer therapy. However, the high energy barriers of reaction intermediates on single-atom sites and the overexpressed antioxidants in the tumor microenvironment restrict the amplification of tumor oxidative stress, resulting in unsatisfactory therapeutic efficacy. Herein, we report a multi-enzyme mimetic MoCu dual-atom nanozyme (MoCu DAzyme) with various catalytic active sites, which exhibits peroxidase, oxidase, glutathione (GSH) oxidase, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase mimicking activities.
View Article and Find Full Text PDFA Host-Guest Approach to Engineering Oxidase-Mimetic Assembly with Substrate Selectivity and Dynamic Catalysis.
ACS Appl Mater Interfaces
August 2024
State Key Laboratory of Organic-Inorganic Composites, Key Lab of Biomedical Materials of Natural Macromolecules (Ministry of Education), Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Article Synopsis
- Synthetic materials that imitate natural systems, like enzymes, pose a significant challenge in biomimicry, specifically in creating selective and responsive catalysts.
- The study presents a strategy using γ-cyclodextrin anchored to a fluorene-modified Lys/Cu assembly, mimicking copper-dependent oxidase, to achieve substrate selectivity and dynamic responsiveness.
- This innovative method demonstrates that substrate binding can be finely tuned through competitive binding agents and light irradiation, paving the way for more versatile biomimetic materials with customizable catalytic properties.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!